Dr. Mark Lewis Joins Board

Mark A. Lewis, MD, Director of Gastrointestinal Oncology, Intermountain Healthcare, Utah, has joined the Board of Directors for the Neuroendocrine Tumor Research Foundation.

Dr. Lewis, who has been personally affected by NETs, brings a unique perspective to the Foundation’s governance. “I aspire to bring to the Board the perspective of a patient-physician (in that order) in prioritizing forward-thinking research that will accelerate the progress of our understanding and care of neuroendocrine tumors and the individuals and families affected by them,” said Dr. Lewis.

“Mark Lewis is a respected advocate in the NET community,” said Elyse Gellerman, NETRF Chief Executive Officer. “His passion and purpose are informed by the experience of having been on both sides of a hospital bed. This perspective enhances our ability to serve the NET patient community.” 

Dr. Lewis is a medical oncologist specializing in cancers of the gastrointestinal tract and accessory organs. He has interests in young-onset cancers and hereditary cancer syndromes, shared decision-making, and patient-physician communication.  As part of his clinical research activities, Dr. Lewis is active in the SWOG Cancer Research Network, a clinical trials cooperative group created by the National Cancer Institute; within SWOG he chairs Adolescent & Young Adult (AYA) Oncology.

A published researcher, Dr. Lewis has also served as a reviewer for multiple peer-reviewed journals.  After attending Baylor College of Medicine, where he also served as resident and chief resident, Dr. Lewis completed a fellowship at Mayo Clinic.

Dr. Lewis is Vice President of American Multiple Endocrine Neoplasia Support, serves on the communications committee for the North American Neuroendocrine Tumor Society, and is an active member of the American Society of Clinical Oncology. 

In his own words

Hear Dr. Mark Lewis tell the story of the familial risk factors for neuroendocrine cancer passed down in his family. This video was produced as part of Healthy Dialogues,  programming offered by Intermountain Healthcare, where Dr. Lewis serves as Director of GI oncology. 

Dr. Lewis writes about what he learned from his whipple procedure 

I have learned this one undeniable truth: for all the studied intellect of doctors, and the incredible array of diagnostic testing by which they can refine their hypotheses, there is no force in medicine more positive and powerful than the self-advocating patient.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  Subscribe  
Notify of

Dr. Mark Lewis Joins Board